Literature DB >> 11471608

Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization.

C Procacci1, G Carbognin, S Accordini, C Biasiutti, E Bicego, L Romano, A Guarise, S Minniti, N Pagnotta, M Falconi.   

Abstract

The aim of this study was to assess the ability of spiral CT to adequately characterize the nonfunctioning endocrine tumors (NFETs) of the pancreas, distinguishing this lesion from the other pancreatic tumors. The spiral CT examinations of 21 cases of histologically proven NFETs, along with those of 29 cases of other pancreatic tumors and tumor-like lesions, were retrospectively reviewed in a blinded fashion by two radiologists, in order to correctly classify the lesions, highlighting the typical signs reported in the literature. Discordant cases were further analyzed in the presence of a third radiologist. The final diagnosis was acquired by means of a majority or overall consensus. The histopathologic examination was considered the gold standard. The sensitivity, specificity, and positive and negative predictive values of CT were calculated. After the consensus evaluation, the correct diagnosis was reached in 72% of cases, with 10% of nonspecific diagnoses of solid pancreatic tumor and 18% of wrong diagnoses. The sensitivity and specificity of spiral CT in identifying NFETs were 66.6 and 82.7%, respectively. The positive and negative predictive values were 73.7 and 77.4%, respectively. In up to 70% of cases the NFET demonstrates a typical aspect of a mass hyperdense in the arterial contrastographic phase eventually associated with hyperdense hepatic metastases in more than half of the patients. This finding does allow the diagnosis of NFET but without certainty indeed, since other tumors can show a similar densitometric behavior and among them particularly the ductal adenocarcinoma. On the other hand, both the solid, hypovascularized NFETs, and the cystic form, cannot be differentiated from the other solid and cystic tumors of the pancreas.

Entities:  

Mesh:

Year:  2001        PMID: 11471608     DOI: 10.1007/s003300000714

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Contrast-enhanced ultrasound of the pancreas.

Authors:  Mirko D'Onofrio; Anna Gallotti; Francesco Principe; Roberto Pozzi Mucelli
Journal:  World J Radiol       Date:  2010-03-28

2.  II. The Endocrine and Pancreatic Unit at the University of Verona, Italy.

Authors:  A A Gumbs
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

3.  Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Ji Li; Guopei Luo; Deliang Fu; Chen Jin; Sijie Hao; Feng Yang; Xiaoyi Wang; Lie Yao; Quanxing Ni
Journal:  Med Oncol       Date:  2010-07-10       Impact factor: 3.064

4.  Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.

Authors:  Giovanni Foti; Letizia Boninsegna; Massimo Falconi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-07-25       Impact factor: 3.469

Review 5.  Primary pancreatic paraganglioma: a report of two cases and literature review.

Authors:  Lei Meng; Jin Wang; Song-Hua Fang
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 6.  Imaging of neuroendocrine gastroenteropancreatic tumours.

Authors:  R Graziani; A Brandalise; M Bellotti; R Manfredi; A Contro; M Falconi; L Boninsegna; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-03-09       Impact factor: 3.469

Review 7.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 8.  Morphological and functional investigations of neuroendocrine tumors of the pancreas.

Authors:  Philippe L Pereira; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2003-05-06       Impact factor: 5.315

9.  Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.

Authors:  Jung Hoon Kim; Hyo Won Eun; Young Jae Kim; Jeong Min Lee; Joon Koo Han; Byung-Ihn Choi
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

10.  Management of nonfunctioning islet cell tumors.

Authors:  Han Liang; Pu Wang; Xiao-Na Wang; Jia-Cang Wang; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.